Cited by 541PI3K/AKT/mTOR signaling in cancerNF-κB Signaling PathwaysImmune Response and Inflammation

PI3K signalling in inflammation

Open access
Hawkins, P.T., Stephens, L.R.·2015·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Abstract

PI3Ks regulate several key events in the inflammatory response to damage and infection. There are four Class I PI3K isoforms (PI3Kα,β,γ,δ), three Class II PI3K isoforms (PI3KC2α, C2β, C2γ) and a single Class III PI3K. The four Class I isoforms synthesise the phospholipid 'PIP3'. PIP3 is a 'second messenger' used by many different cell surface receptors to control cell movement, growth, survival and differentiation. These four isoforms have overlapping functions but each is adapted to receive efficient stimulation by particular receptor sub-types. PI3Kγ is highly expressed in leukocytes and plays a particularly important role in chemokine-mediated recruitment and activation of innate immune cells at sites of inflammation. PI3Kδ is also highly expressed in leukocytes and plays a key role in antigen receptor and cytokine-mediated B and T cell development, differentiation and function. Class III PI3K synthesises the phospholipid PI3P, which regulates endosome-lysosome trafficking and the induction of autophagy, pathways involved in pathogen killing, antigen processing and immune cell survival. Much less is known about the function of Class II PI3Ks, but emerging evidence indicates they can synthesise PI3P and PI34P2 and are involved in the regulation of endocytosis. The creation of genetically-modified mice with altered PI3K signalling, together with the development of isoform-selective, small-molecule PI3K inhibitors, has allowed the evaluation of the individual roles of Class I PI3K isoforms in several mouse models of chronic inflammation. Selective inhibition of PI3Kδ, γ or β has each been shown to reduce the severity of inflammation in one or more models of autoimmune disease, respiratory disease or allergic inflammation, with dual γ/δ or β/δ inhibition generally proving more effective. The inhibition of Class I PI3Ks may therefore offer a therapeutic opportunity to treat non-resolving inflammatory pathologies in humans. This article is part of a Special Issue entitled Phosphoinositides.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbalip.2014.12.006

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 9

  1. D.K. Finlay, mTORC1 regulates CD8+ T-cell glucose metabolism and function independently of PI3K and PKB, Biochem. Soc. Trans. 41 (2013) 681-686.
  2. B. Kurig, A. Shymanets, T. Bohnacker, Brock C. Prajwal, et al., Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110gamma, Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 20312-20317.
  3. O. Vadas, H.A. Dbouk, A. Shymanets, O. Perisic, J.E. Burke, et al., Molecular determinants of PI3Kgamma-mediated activation downstream of G-protein-coupled receptors (GPCRs), Proc. Natl. Acad. Sci. U. S. A. 110 (2013) 18862-18867.
  4. J.D. Chang, G.K. Sukhova, P. Libby, E. Schvartz, A.H. Lichtenstein, et al., Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 8077-8082.
  5. J. Guillermet-Guibert, K. Bjorklof, A. Salpekar, C. Gonella, F. Ramadani, et al., The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 8292-8297.
  6. M.J. Rauh, J. Kalesnikoff, M. Hughes, L. Sly, V. Lam, et al., Role of Src homology 2-containing-inositol 5'-phosphatase (SHIP) in mast cells and macrophages, Biochem. Soc. Trans. 31 (2003) 286-291.
  7. M. Gigoux, J. Shang, Y. Pak, M. Xu, J. Choe, et al., Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase, Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 20371-20376.
  8. W.C. Rowan, J.L. Smith, K. Affleck, A. Amour, Targeting phosphoinositide 3-kinase delta for allergic asthma, Biochem. Soc. Trans. 40 (2012) 240-245.
  9. T. Willinger, R.A. Flavell, Canonical autophagy dependent on the class III phosphoinositide-3 kinase Vps34 is required for naive T-cell homeostasis, Proc. Natl. Acad. Sci. U. S. A. 109 (2012) 8670-8675.

Cited by

Sorted by citations

Authors
Hawkins, P. T., & Stephens, L. R.
Affiliations
Babraham Institute (GB)
Corresponding author
  • Hawkins, P.T.
  • Stephens, L.R.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Publisher
Elsevier BV
Published
2015-06
Volume
1851
Issue
6
Pages
882-897
ISSN
1388-1981 (ISSN-L)
OpenAlex
W2028549997
Cited by
541
References
12
Citations by year
2026: 33 · 2025: 55 · 2024: 45 · 2023: 56 · 2022: 52 · 2021: 66 · 2020: 45 · 2019: 60 · 2018: 44 · 2017: 43 · 2016: 24 · 2015: 15 · 2014: 1 · 2012: 1
FWCI
2.60
Type
journal article
Language
en
Open access
Locations
  • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Biotechnology and Biological Sciences Research Council (ISPG BB/J004456/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
PI3K signaling, inflammation, class II PI3K, class III PI3K, phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-phosphate, PI3Kδ, PI3Kγ, PI3Kβ, PI3K inhibitors, leukocyte chemotaxis, autophagy, endocytosis, autoimmune disease, allergic inflammation, respiratory diseases, chronic inflammation
MeSH terms
Phosphoinositide-3 Kinase Inhibitors, Animals, Autophagy, Biological Transport, Enzyme Inhibitors, Gene Expression Regulation, Humans, Immunity, Innate, Inflammation, Isoenzymes, Mice, Transgenic, Phosphatidylinositols, Endosomes, Signal Transduction, Phosphatidylinositol 3-Kinases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review